Dr Kneeland Youngblood - Jun 5, 2024 Form 4 Insider Report for Light & Wonder, Inc. (LNW)

Role
Director
Signature
/s/ James Sottile, attorney-in-fact for Dr. Kneeland Youngblood
Stock symbol
LNW
Transactions as of
Jun 5, 2024
Transactions value $
$0
Form type
4
Date filed
6/7/2024, 04:54 PM
Previous filing
Jan 25, 2024
Next filing
Jun 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LNW Common Stock Options Exercise $0 +3.32K +16.12% $0.00 23.9K Jun 7, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LNW Restricted Stock Units Award $0 +2.16K $0.00 2.16K Jun 5, 2024 Common Stock 2.16K Direct F1
transaction LNW Restricted Stock Units Options Exercise $0 -3.32K -100% $0.00* 0 Jun 7, 2024 Common Stock 3.32K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis.
F2 Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis.